Home › NDC Lookup › RxCUI directory › RxCUI 2668391

15 ML mirikizumab-mrkz 20 MG/ML Injection — RxCUI 2668391

RxNorm drug concept · Semantic clinical drug
RxCUI 2668391 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2668391
Official name15 ML mirikizumab-mrkz 20 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmirikizumab-mrkz 300 MG per 15 ML Injection; mirikizumab-mrkz 300 MG in 15 ML Injection
FDA products mapped7
Package NDCs mapped10
Reported Medicaid activity (SDUD)123 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mirikizumab-Mrkz: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Omvoh is a biologic medication — a lab-engineered protein that targets a very specific part of your immune system called IL-23. IL-23 is a signaling molecule that drives the gut in...
  • What exactly is Omvoh and how is it different from other IBD treatments?
  • No — only at the start. The first three doses are intravenous infusions given at a clinic at Weeks 0, 4, and 8. After that, starting at Week 12, you switch to subcutaneous injectio...
  • Do I have to keep going to the clinic for infusions the whole time?
📖 Read our full Mirikizumab-Mrkz guide →

🕸️ Concept Web — How 15 ML mirikizumab-mrkz 20 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 15 ML mirikizumab-mrkz 20 MG/ML Injection RxCUI 2668391

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Mirikizumab 2668384
    • Mirikizumab-mrkz 2668385
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Omvoh 2668393
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mirikizumab Injection 2668388
    • Mirikizumab-mrkz Injection 2668390
    • Mirikizumab Injectable Product 2668387
    • Mirikizumab-mrkz Injectable Product 2668389
    • Mirikizumab Injection [Omvoh] 2668396
    • Mirikizumab-mrkz Injection [Omvoh] 2668397
    • Omvoh Injectable Product 2668395
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mirikizumab-mrkz 20 MG/ML SCDC · 2668386
  • Mirikizumab Injection SCDF · 2668388
  • Mirikizumab-mrkz Injection SCDFP · 2668390
  • Mirikizumab Injectable Product SCDG · 2668387
  • Mirikizumab-mrkz Injectable Product SCDGP · 2668389

Brand-Name Concepts

  • 15 ML mirikizumab-mrkz 20 MG/ML Injection [Omvoh] SBD · 2668398
  • Mirikizumab-mrkz 20 MG/ML [Omvoh] SBDC · 2668394
  • Mirikizumab Injection [Omvoh] SBDF · 2668396
  • Mirikizumab-mrkz Injection [Omvoh] SBDFP · 2668397
  • Omvoh Injectable Product SBDG · 2668395
  • Omvoh BN · 2668393

📦 FDA Products & Package NDCs

7 products · 10 package NDCs
10 package NDCs map to RxCUI 2668391 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-1442-11 1 SYRINGE in 1 CARTON (0002-1442-11) / 2 mL in 1 SYRINGE (0... Omvoh Eli Lilly and Company 2025-10-23
00002-3116-11 1 SYRINGE in 1 CARTON (0002-3116-11) / 2 mL in 1 SYRINGE (0... Omvoh Eli Lilly and Company 2025-10-23
00002-3116-61 1 SYRINGE in 1 CARTON (0002-3116-61) / 2 mL in 1 SYRINGE Omvoh Eli Lilly and Company 2025-11-06
00002-7575-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7575-01) / 15 mL in 1... Omvoh Eli Lilly and Company 2023-10-26
00002-7717-11 1 KIT in 1 CARTON (0002-7717-11) * 1 mL in 1 SYRINGE * 2... Omvoh Eli Lilly and Company 2025-01-15
00002-7717-61 1 KIT in 1 CARTON (0002-7717-61) * 1 mL in 1 SYRINGE * 2... Omvoh Eli Lilly and Company 2025-01-15
00002-7722-11 1 KIT in 1 CARTON (0002-7722-11) * 1 mL in 1 SYRINGE (0002... Omvoh Eli Lilly and Company 2025-01-15
00002-8011-27 2 SYRINGE in 1 CARTON (0002-8011-27) / 1 mL in 1 SYRINGE (0... Omvoh Eli Lilly and Company 2023-10-26
00002-8011-61 2 SYRINGE in 1 CARTON (0002-8011-61) / 1 mL in 1 SYRINGE Omvoh Eli Lilly and Company 2024-01-16
00002-8870-27 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0... Omvoh Eli Lilly and Company 2024-04-29
Observed labelers: Eli Lilly and Company (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2267 Inj, mirikizumab-mrkz, 1 mg 7 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.